Areas of Focus
- Somatic cell reprogramming
- Molecular mechanisms of cell fate regulation
- Regenerative medicine, tissue and organ regeneration
- Immune therapy for cancer
Work Experience
- Current - Peking University, Director of Stem Cell Research Center
- Current - Peking University, Chair of the Department of Cell Biology, School of Basic Medical Sciences
- Current - Joint Researcher at Peking University-Tsinghua University Center for Life Sciences
Academic Background & Achievements
- 1980-1984: Bachelor's Degree from Wuhan University, China
- 1984-1987: Master's Degree from Second Military Medical University, Shanghai, China
- 1990-1995: PhD from University of California, Los Angeles, USA
- 1995-1997: Postdoctoral Research at New York University Medical Center, USA
Publications
- Chemical reprogramming of human somatic cells to pluripotent stem cells, Deng, H. et al., 2022
- Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates, Deng, H. et al., 2022
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia, Deng, H. et al., 2019
- Long-term functional maintenance of primary human hepatocytes in vitro, Deng, H. et al., 2019
- Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs during Chemical Reprogramming, Deng, H. et al., 2018
